Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients
- PMID: 33501645
- PMCID: PMC8013767
- DOI: 10.1002/jmv.26821
Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients
Abstract
Background: The ongoing coronavirus disease 2019 (Covid-19) pandemic has been rapidly spreading throughout the world with confirmed case numbers already exceeding 75 million. Although nasopharyngeal swabs are the most commonly utilized samples for based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA detection, collecting these specimens requires healthcare workers and necessitates the use of personal protective equipment as it presents a nosocomial transmission risk. We aimed to assess the diagnostic value of saliva samples in mildly symptomatic and asymptomatic patients with confirmed Covid-19.
Methods: We performed a cohort study to validate the use of saliva for SARS-CoV-2 detection in mildly symptomatic and asymptomatic patients with a confirmed diagnosis of Covid-19. Saliva samples of the patients were analyzed by reverse-transcriptase polymerase chain reaction (RT-PCR).
Results: In May 2020, 28 asymptomatic and 25 mildly symptomatic patients were enrolled in the study. The median age was 37 years (range 4-70). None of the patients had a fever on presentation. Among 53 patients with SARS-CoV-2 detected in the nasopharyngeal sample, the real-time RT-PCR was positive in the saliva specimens in 48 (90.56%) patients. The mean cycle threshold (CT) values for nasopharyngeal and saliva specimens (27.80 ± 3.44 and 30.64 ± 2.83, respectively) were significantly correlated between the two sample types (p = .016). The mean CT values of nasopharyngeal and saliva samples in mildly symptomatic and asymptomatic patients (27.18 ± 3.53 and 30.24 ± 3.29 vs. 28.36 ± 3.31 and 30.98 ± 2.39, respectively) were not significantly different (p = .236 and p = .733, respectively).
Conclusions: Saliva specimens can be considered as a reliable and less resource-intensive alternative to nasopharyngeal specimens for screening asymptomatic SARS-CoV-2 infections.
Keywords: Covid-19; RT-PCR; SARS-CoV-2; diagnosis; saliva.
© 2021 Wiley Periodicals LLC.
Figures
Similar articles
-
Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.Microbiol Spectr. 2021 Dec 22;9(3):e0046821. doi: 10.1128/Spectrum.00468-21. Epub 2021 Nov 3. Microbiol Spectr. 2021. PMID: 34730436 Free PMC article.
-
Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.Microbiol Spectr. 2021 Sep 3;9(1):e0006221. doi: 10.1128/Spectrum.00062-21. Epub 2021 Aug 25. Microbiol Spectr. 2021. PMID: 34431689 Free PMC article.
-
Performance of Self-Collected Saliva Testing Compared with Nasopharyngeal Swab Testing for the Detection of SARS-CoV-2.Viruses. 2021 May 12;13(5):895. doi: 10.3390/v13050895. Viruses. 2021. PMID: 34066046 Free PMC article.
-
Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis.J Med Virol. 2021 Feb;93(2):719-725. doi: 10.1002/jmv.26349. Epub 2020 Aug 2. J Med Virol. 2021. PMID: 32706393 Free PMC article.
-
Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review.Rev Med Virol. 2021 Jul;31(4):e2185. doi: 10.1002/rmv.2185. Epub 2020 Oct 22. Rev Med Virol. 2021. PMID: 33091200 Review.
Cited by
-
The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19.Chin Med. 2021 Jun 7;16(1):44. doi: 10.1186/s13020-021-00454-x. Chin Med. 2021. PMID: 34099015 Free PMC article. Review.
-
Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals.Microbiol Spectr. 2022 Jun 29;10(3):e0226421. doi: 10.1128/spectrum.02264-21. Epub 2022 May 16. Microbiol Spectr. 2022. PMID: 35575498 Free PMC article.
-
Saliva as an alternative specimen to nasopharyngeal swabs for COVID-19 diagnosis: Review.Access Microbiol. 2022 May 20;4(5):acmi000366. doi: 10.1099/acmi.0.000366. eCollection 2022 Aug. Access Microbiol. 2022. PMID: 36003360 Free PMC article. Review.
-
A Holistic Approach for Ethics and Sustainability in the Food Chain: The Gateway to Oral and Systemic Health.Foods. 2024 Apr 17;13(8):1224. doi: 10.3390/foods13081224. Foods. 2024. PMID: 38672896 Free PMC article. Review.
-
Comparison of SARS-CoV-2 RNA detection in different types of clinical specimens among suspected COVID-19 patients in Addis Ababa, Ethiopia.Virusdisease. 2024 Dec;35(4):567-576. doi: 10.1007/s13337-024-00892-9. Epub 2024 Nov 9. Virusdisease. 2024. PMID: 39677841
References
-
- World Health Organization . Coronavirus disease (COVID‐19) situation report. https://www.who.int/docs/default-source/coronaviruse/20200630-covid-19-s... (accessed December 20, 2020).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous